The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

The funds will be used to increase the development of GAIA-based Alzheimer's disease drugs and widen the pipeline of blockbuster drug candidates.

Developing an AI platform internally can be more cost-effective and manageable, said Ryan Sadeghian, chief medical information officer at the University of Toledo, at HIMSS AI Forum.

The new firm, TandemAI will offer partners an expanded range of methods and workflows for small-molecule and peptide drug ...

Through the alliance, Hippocratic AI's generative AI healthcare agents will be constructed for "patient-facing non-diagnostic ...

Unveiled at Galaxy Unpacked, the new lineup includes sleep apnea detection, vascular stress monitoring and the first ...

Constant Therapy , a digital health company specializing in speech-language Therapy, is collaborating with Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients ...

OpenEvidence , an AI-enabled medical research aggregate platform for doctors, has scored $210 million in Series B funding, boosting the company's valuation to $3.5 billion. The round was co-led by ...

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.

The company will use the funds to move into the female health space and increase screening and preventive care.

The organizations will co-develop AI playbooks, tools, a new certification program and best practices for health AI.

The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more ...